Odyssean LLC’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Odyssean LLC's KRYS Position: Q3 2026 in Review
Odyssean LLC increased its Krystal Biotech (KRYS) stake by 26% in Q3 2026, buying an estimated $853K and bringing the position to 11,813 shares worth $3.93M. The position accounts for 0.45% of the portfolio, ranked #102.
Odyssean LLC first reported a position in KRYS in Q4 2025 and has held it in 4 quarters since. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Odyssean LLC held 11,813 shares of Krystal Biotech worth $3.93M as of Q3 2026.
- Odyssean LLC bought 2,464 Krystal Biotech shares in Q3 2026, an estimated $853K.
- Krystal Biotech made up 0.45% of Odyssean LLC's portfolio in Q3 2026, its #102 holding.
- Odyssean LLC first reported a position in Krystal Biotech in Q4 2025 and has held it in 4 quarters since.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.